MGF

What is MGF?

MGF stands for mechano growth factor. It is a version of insulin-like growth factor 1 (IGF-1) that muscle makes for itself after it is stretched, overloaded or damaged. Scientists call it IGF-1Ec in humans, after the particular way the IGF-1 gene is spliced to produce it.

It was described in the late 1990s by Geoffrey Goldspink's group in London, who cloned different forms of IGF-1 from exercised muscle. One of them was only detectable after injury or mechanical activity, so they named it mechano growth factor.⁶ The group proposed that it acts as a local repair signal rather than a hormone that circulates around the body.

MGF is not an approved drug. A synthetic peptide based on its unique tail is sold online as a research chemical, mostly to bodybuilders who hope it will help muscles grow and recover. It is banned in sport.

How MGF works

Muscle fibers cannot divide. To grow or repair, they rely on a pool of stem cells called satellite cells that sit along the fiber, wake up after damage, multiply and fuse into the fiber to add new nuclei. The theory is that MGF is the early wake-up signal for those cells, released in a pulse after hard exercise or injury. Ordinary IGF-1 then takes over to drive protein building.⁷

That theory also explains the interest in aging. Older muscles appear less able to switch on MGF after exercise, which might be one reason they repair and grow less well.¹

In more precise terms, alternative splicing of the IGF-1 gene produces precursor proteins with different E-domain tails. In MGF, a reading-frame shift gives a distinct C-terminal sequence and a different mode of action from liver IGF-1.⁶ The peptide sold as MGF is usually a synthetic version of this E-domain tail, about 24 amino acids long, rather than the full precursor. The original group proposed that this distinct sequence is what replenishes the satellite cells.¹ It is thought to act apart from the standard IGF-1 receptor, but the mechanism is still poorly understood.⁴

What the research shows on MGF

Almost all the research is in cells and animals. In animal models, MGF expression rises in muscle, bone and tendon after mechanical damage and in brain and heart after loss of blood supply. MGF and its short peptide have been tested as experimental therapies for muscular dystrophy and brain injury in animals.⁴ In animal muscle, MGF has been shown to activate satellite cells, leading to hypertrophy or regeneration.⁴

Human work is observational. Studies taking muscle biopsies before and after resistance exercise found that MGF messenger RNA rises after short-term high-resistance exercise in young people but not in older people.⁵ Other work suggested that growth hormone treatment combined with resistance training shifted IGF-1 splicing toward MGF in older adults.¹ These studies measure the body's own MGF gene activity. They do not test injecting a synthetic peptide.

That gap is the key point. There are no published controlled trials of injected MGF peptide in humans for muscle growth, recovery or any disease. Some independent labs have also had trouble reproducing the claim that the E-domain peptide acts separately from IGF-1, so the basic biology is still debated.

Studied for: Satellite cell activation research, Muscle repair studies.

MGF reference data

MGF dosage in published research

Open this in the dosage calculator ↗

How MGF is used in practice

MGF is not prescribed by US doctors or telehealth services, and it is not a lawful compounding ingredient. It is bought as freeze-dried powder from research-chemical sites, mixed with bacteriostatic water and injected, often straight into a trained muscle right after a workout. The practice is based on the local, pulsed way the body releases its own MGF. Some sellers also market it for tendon, joint and even brain recovery, pointing to animal work on MGF in bone, tendon and brain injury.⁴ None of those uses has been tested in people.

The native peptide breaks down in minutes in blood, which is why vendors also sell a pegylated version. There is no evidence that injecting the short peptide reproduces what natural MGF does inside muscle. Bodybuilding interest was flagged early by researchers, who warned that a factor that kick-starts hypertrophy had obvious abuse potential.²

Quality is a real issue. Research-chemical peptides have no checks on identity, purity, dose or sterility. A fragile peptide that degrades quickly is especially likely to arrive inactive or contaminated.

MGF risks and side effects

Because there are no human trials, there is no reliable list of side effects. Users report injection-site soreness, redness and fatigue. Intramuscular injection of non-sterile products risks infection and abscesses. Because MGF is related to IGF-1, low blood sugar is a theoretical concern, especially if it is combined with insulin or IGF-1 analogs, but this has not been measured.

The theoretical concern is cancer. MGF is part of the IGF-1 system, which promotes cell growth and survival, and IGF-1 signaling is involved in many tumors. Anyone with active or suspected cancer, or a strong history of it, should avoid it. It should not be used in pregnancy. Interactions with insulin, growth hormone and other peptides are uncharacterized.

For competitive athletes, MGF is on the World Anti-Doping Agency's prohibited list, and testing methods for IGF-1 analogs exist.

Reported side effects

Alternatives to MGF

The most reliable way to raise your own MGF and build muscle is progressive resistance training, which works even in older adults.³ Adequate protein intake, creatine monohydrate and good sleep have solid evidence for muscle size and strength. For recovery between hard sessions, planned rest days, enough total calories and sensible training volume do more than any injected product.

For people with diagnosed growth hormone deficiency, approved somatropin products are the medical option. For age-related muscle loss, there is no approved drug, and supervised exercise remains the standard treatment.

Questions for a clinician

• What evidence applies to my situation, and at what level?
• What established alternatives should I consider first?
• What monitoring would be necessary, and how often?
• Can this be prescribed at all where I live, or only sold for research?